GenoFocus Inc (187420) — Cash Flow Quality Index
GenoFocus Inc (187420) has a Cash Flow Quality Index of 0.03x as of December 2025. Operating cash flow of ₩288.09 Million is below net income of ₩9.06 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does GenoFocus Inc generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
GenoFocus Inc Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for GenoFocus Inc across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 187420 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for GenoFocus Inc (2014–2025)
Year-by-year earnings quality comparison for GenoFocus Inc. For live market cap and the full company financial profile, see 187420 stock market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | ₩3.50 Billion | ₩22.59 Billion | ▼ -84.0% |
| 2017 | 0.97x | ₩1.36 Billion | ₩1.41 Billion | ▲ +202.5% |
| 2016 | 0.32x | ₩516.09 Million | ₩1.61 Billion | ▼ -86.4% |
| 2015 | 2.36x | ₩2.85 Billion | ₩1.21 Billion | ▲ +1894.5% |
| 2014 | -0.13x | ₩-286.45 Million | ₩2.18 Billion | — |